File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Defining conversion therapy for esophageal squamous cell carcinoma

TitleDefining conversion therapy for esophageal squamous cell carcinoma
Authors
Matsuda, SatoruTsushima, TakahiroKato, KenHsu, Chih‐HungLee, Jang MingWong, Ian Yu‐HongWang, Hu‐Lin ChristinaKang, Chang HyunGuo, XufengYamamoto, ShunTsuji, TakayukiKawakubo, HirofumiTakeuchi, HiroyaLaw, SimonKitagawa, Yuko
Keywordsconversion surgery
conversion therapy
esophageal squamous cell carcinoma
Issue Date19-Oct-2022
PublisherJohn Wiley & Sons Inc.
Citation
Annals of Gastroenterological Surgery, 2022, v. 7, n. 1, p. 7-9 How to Cite?
DOI: http://dx.doi.org/10.1002/ags3.12623
Abstract

A multimodality treatment conference with experts from across East Asia was held to establish a consensus for conversion therapy. An agreement was reached that conversion therapy was defined as surgery or chemoradiotherapy (CRT) aiming at cure after initial treatment for tumors that were initially unresectable due to adjacent organ invasion or distant metastasis.


Persistent Identifierhttp://hdl.handle.net/10722/331652
ISSN
2475-0328
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 1.259
ISI Accession Number ID
WOS:000869784800001

 

DC FieldValueLanguage
dc.contributor.authorMatsuda, Satoru-
dc.contributor.authorTsushima, Takahiro-
dc.contributor.authorKato, Ken-
dc.contributor.authorHsu, Chih‐Hung-
dc.contributor.authorLee, Jang Ming-
dc.contributor.authorWong, Ian Yu‐Hong-
dc.contributor.authorWang, Hu‐Lin Christina-
dc.contributor.authorKang, Chang Hyun-
dc.contributor.authorGuo, Xufeng-
dc.contributor.authorYamamoto, Shun-
dc.contributor.authorTsuji, Takayuki-
dc.contributor.authorKawakubo, Hirofumi-
dc.contributor.authorTakeuchi, Hiroya-
dc.contributor.authorLaw, Simon-
dc.contributor.authorKitagawa, Yuko-
dc.date.accessioned2023-09-21T06:57:42Z-
dc.date.available2023-09-21T06:57:42Z-
dc.date.issued2022-10-19-
dc.identifier.citationAnnals of Gastroenterological Surgery, 2022, v. 7, n. 1, p. 7-9-
dc.identifier.issn2475-0328-
dc.identifier.urihttp://hdl.handle.net/10722/331652-
dc.description.abstract<p></p><p>A multimodality treatment conference with experts from across East Asia was held to establish a consensus for conversion therapy. An agreement was reached that conversion therapy was defined as surgery or chemoradiotherapy (CRT) aiming at cure after initial treatment for tumors that were initially unresectable due to adjacent organ invasion or distant metastasis.<br></p>-
dc.languageeng-
dc.publisherJohn Wiley & Sons Inc.-
dc.relation.ispartofAnnals of Gastroenterological Surgery-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectconversion surgery-
dc.subjectconversion therapy-
dc.subjectesophageal squamous cell carcinoma-
dc.titleDefining conversion therapy for esophageal squamous cell carcinoma-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1002/ags3.12623-
dc.identifier.scopuseid_2-s2.0-85139992526-
dc.identifier.volume7-
dc.identifier.issue1-
dc.identifier.spage7-
dc.identifier.epage9-
dc.identifier.eissn2475-0328-
dc.identifier.isiWOS:000869784800001-
dc.identifier.issnl2475-0328-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats